Tag: Virtual ACC
Virtual ACC: Caravaggio study confirms noninferiority of apixaban to heparin for...
It has been found that oral apixaban is noninferior to subcutaneous dalteparin for the treatment of cancer-related venous thromboembolism (VTE), as revealed by Giancarlo...
Virtual ACC: Rivaroxaban demonstrates superiority over enoxaparin for prevention of VTE...
Results of PRONOMOS, a randomised, controlled, noninferiority trial, have shown rivaroxaban to be more effective than enoxaparin in the prevention of major venous thromboembolic...